line
Japanese Society for Palliative Medicine
News Letter No.92
日本緩和医療学会ニューズレター
Aug 2021  92
Journal Watch
緩和ケアに関する論文レビュー
名古屋大学大学院医学系研究科 総合保健学専攻高度実践看護開発学講座
佐藤 一樹

対象雑誌:N Engl J Med, Lancet, Lancet Oncol, JAMA, JAMA Intern Med, JAMA Oncol, BMJ, Ann Intern Med, J Clin Oncol, Ann Oncol, Eur J Cancer, Br J Cancer, Cancer

対象期間:2021年3月〜5月刊行分

いわゆる“トップジャーナル”に掲載された緩和ケアに関する最新論文を広く紹介します。


【N Engl J Med. 2021;384(9-21)】
なし

【Lancet. 397(10277-10289)】
なし

【Lancet Oncol. 2021;22(3-5)】
なし

【JAMA. 2021;325(9-20)】
1. 小児の慢性疼痛治療のWHOの新しいガイドライン
Kuehn BM. New WHO Guideline for Treating Chronic Pain in Children. JAMA. 2021;325(11):1031. [PMID: 33724333]

【JAMA Intern Med. 2021;7(3-5)】
2. 高齢者対象のACPの看護師主導の多職種介入の無作為化比較試験
Gabbard J, Pajewski NM, Callahan KE, Dharod A, Foley KL, Ferris K, et al. Effectiveness of a Nurse-Led Multidisciplinary Intervention vs Usual Care on Advance Care Planning for Vulnerable Older Adults in an Accountable Care Organization: A Randomized Clinical Trial. JAMA Intern Med. 2021;181(3):361-9. [PMID: 33427851]

【JAMA Oncol. 2021;181(3-5)】
3. がん疼痛でオピオイド鎮痛薬処方のあるがん患者のオピオイド乱用とその要因
Yennurajalingam S, Arthur J, Reddy S, Edwards T, Lu Z, Rozman de Moraes A, et al. Frequency of and Factors Associated With Nonmedical Opioid Use Behavior Among Patients With Cancer Receiving Opioids for Cancer Pain. JAMA Oncol. 2021;7(3):404-11. [PMID: 33410866]
4. COVID-19パンデミック禍のがんセンターでのバーチャルケアの効果
Berlin A, Lovas M, Truong T, Melwani S, Liu J, Liu ZA, et al. Implementation and Outcomes of Virtual Care Across a Tertiary Cancer Center During COVID-19. JAMA Oncol. 2021;7(4):597-602. [PMID: 33410867]
5. がん患者の筋骨格の慢性痛に対する電気鍼治療・耳鍼治療の無作為化比較試験:PEACE試験
Mao JJ, Liou KT, Baser RE, Bao T, Panageas KS, Romero SAD, et al. Effectiveness of Electroacupuncture or Auricular Acupuncture vs Usual Care for Chronic Musculoskeletal Pain Among Cancer Survivors: The PEACE Randomized Clinical Trial. JAMA Oncol. 2021;7(5):720-7. [PMID: 33734288]

【BMJ. 2021; 372(8282-8285), 373(8286-8293)】
6. 不安・抑うつ評価尺度HADSによる大うつ病スクリーニングの正確さのメタアナリシス
Wu Y, Levis B, Sun Y, He C, Krishnan A, Neupane D, et al. Accuracy of the Hospital Anxiety and Depression Scale Depression subscale (HADS-D) to screen for major depression: systematic review and individual participant data meta-analysis. BMJ. 2021;373:n972.[PMID: 33972268]

【Ann Intern Med. 2021;175(3-5)】
7. COVID-19パンデミック禍での終末期ケアに関する医療者の認識
Cook DJ, Takaoka A, Hoad N, Swinton M, Clarke FJ, Rudkowski JC, et al. Clinician Perspectives on Caring for Dying Patients During the Pandemic : A Mixed-Methods Study. Ann Intern Med. 2021;174(4):493-500. [PMID: 33284683]

【J Clin Oncol. 2020;39(7-15)】
8. 進行がん患者の呼吸困難マネジメント:ASCOガイドライン
Hui D, Bohlke K, Bao T, Campbell TC, Coyne PJ, Currow DC, et al. Management of Dyspnea in Advanced Cancer: ASCO Guideline. J Clin Oncol. 2021;39(12):1389-411.[PMID: 33617290]
9. がん患者の禁煙外来紹介のオプトアウトによる推定同意アプローチ
Ohde JW, Master Z, Tilburt JC, Warner DO. Presumed Consent With Opt-Out: An Ethical Consent Approach to Automatically Refer Patients With Cancer to Tobacco Treatment Services. J Clin Oncol. 2021;39(8):876-80.[PMID: 33439692]
10. AYA世代がんサバイバーの長期的な精神健康障害リスク
De R, Sutradhar R, Kurdyak P, Aktar S, Pole JD, Baxter N, et al. Incidence and Predictors of Mental Health Outcomes Among Survivors of Adolescent and Young Adult Cancer: A Population-Based Study Using the IMPACT Cohort. J Clin Oncol. 2021;39(9):1010-9. [PMID: 33492982]
11. がんサバイバー対象の電話による抑うつセルフケア介入CanDirect
McCusker J, Jones JM, Li M, Faria R, Yaffe MJ, Lambert SD, et al. CanDirect: Effectiveness of a Telephone-Supported Depression Self-Care Intervention for Cancer Survivors. J Clin Oncol. 2021;39(10):1150-61. [PMID: 33555912]
12. びまん性大細胞型B細胞リンパ腫の高齢患者の単純化した高齢者評価
Merli F, Luminari S, Tucci A, Arcari A, Rigacci L, Hawkes E, et al. Simplified Geriatric Assessment in Older Patients With Diffuse Large B-Cell Lymphoma: The Prospective Elderly Project of the Fondazione Italiana Linfomi. J Clin Oncol. 2021;39(11):1214-22. [PMID: 33577377]

【Ann Oncol. 2021;32(3-5)】
13. 欧州の2021年のがん死亡数の予測
Carioli G, Malvezzi M, Bertuccio P, Boffetta P, Levi F, La Vecchia C, et al. European cancer mortality predictions for the year 2021 with focus on pancreatic and female lung cancer. Ann Oncol. 2021;32(4):478-87. [PMID: 33626377]

【Eur J Cancer. 2021;145-149】
なし

【Br J Cancer. 2021;124(3-11)】
14. 各国のがん登録制度とがん患者の予後の関連
Andersson TM, Rutherford MJ, Myklebust TA, Moller B, Soerjomataram I, Arnold M, et al. Exploring the impact of cancer registry completeness on international cancer survival differences: a simulation study. Br J Cancer. 2021;124(5):1026-32. [PMID: 33293692]
15. 脳腫瘍の新規診断患者の炎症スコアと予後の関連
Starzer AM, Steindl A, Mair MJ, Deischinger C, Simonovska A, Widhalm G, et al. Systemic inflammation scores correlate with survival prognosis in patients with newly diagnosed brain metastases. Br J Cancer. 2021;124(7):1294-300. [PMID: 33473170]
16. 膵臓がん患者の悪液質の総説
Kordes M, Larsson L, Engstrand L, Lohr JM. Pancreatic cancer cachexia: three dimensions of a complex syndrome. Br J Cancer. 2021;124(10):1623-36. [PMID: 33742145]

【Cancer. 2021;127(5-10)】
17. 乳がん診断後治療開始までの期間と患者の苦痛の関連
Fayanju OM, Ren Y, Stashko I, Power S, Thornton MJ, Marcom PK, et al. Patient-reported causes of distress predict disparities in time to evaluation and time to treatment after breast cancer diagnosis. Cancer. 2021;127(5):757-68. [PMID: 33175437]
18. 造血幹細胞移植サバイバーの長期的なフレイル評価
Arora M, Chen Y, Wu J, Hageman L, Ness E, Kung M, et al. Longitudinal trajectory of frailty in blood or marrow transplant survivors: Report from the Blood or Marrow Transplant Survivor Study. Cancer. 2021;127(5):794-800. [PMID: 33206383]
19. 化学療法後の就業状況の縦断調査
Tevaarwerk AJ, Kwekkeboom K, Buhr KA, Dennee A, Conkright W, Onitilo AA, et al. Results from a prospective longitudinal survey of employment and work outcomes in newly diagnosed cancer patients during and after curative-intent chemotherapy: A Wisconsin Oncology Network study. Cancer. 2021;127(5):801-8. [PMID: 33231882]
20. 米国の乳がん女性の医療保険の種類と予後との関連
Berrian JL, Liu Y, Lian M, Schmaltz CL, Colditz GA. Relationship between insurance status and outcomes for patients with breast cancer in Missouri. Cancer. 2021;127(6):931-7. [PMID: 33201532]
21. 早期乳がん患者の化学療法の有害事象の年齢比較
Nyrop KA, Deal AM, Chen YT, Reeve BB, Basch EM, Wood WA, et al. Patient-reported symptom severity, interference with daily activities, and adverse events in older and younger women receiving chemotherapy for early breast cancer. Cancer. 2021;127(6):957-67. [PMID: 33216355]
22. がん疼痛でオピオイド鎮痛薬処方のあるがん患者に対する非医療用オピオイド使用の無作為尿検査
Arthur JA, Tang M, Lu Z, Hui D, Nguyen K, Rodriguez EM, et al. Random urine drug testing among patients receiving opioid therapy for cancer pain. Cancer. 2021;127(6):968-75. [PMID: 33231885]
23. 乳がんサバイバーの妊娠の関連要因
Poorvu PD, Gelber SI, Zheng Y, Ruddy KJ, Tamimi RM, Peppercorn J, et al. Pregnancy after breast cancer: Results from a prospective cohort of young women with breast cancer. Cancer. 2021;127(7):1021-8. [PMID: 33259061]
24. 黒人がん患者と腫瘍医の非言語的コミュニケーション
Hamel LM, Moulder R, Harper FWK, Penner LA, Albrecht TL, Eggly S. Examining the dynamic nature of nonverbal communication between Black patients with cancer and their oncologists. Cancer. 2021;127(7):1080-90. [PMID: 33290592]
25. 乳がん健康関連QOLと予後の関連
Park J, Rodriguez JL, O'Brien KM, Nichols HB, Hodgson ME, Weinberg CR, et al. Health-related quality of life outcomes among breast cancer survivors. Cancer. 2021;127(7):1114-25. [PMID: 3323760]
26. 小児がん患者の親に対するコミュニケーション促進介入Day 100 Talkの実施可能性
Feraco AM, McCarthy SR, Revette AC, Stevens SE, Das PJ, Al-Sayegh H, et al. Feasibility and acceptability of the "Day 100 Talk": An interdisciplinary communication intervention during the first six months of childhood cancer treatment. Cancer. 2021;127(7):1134-45. [PMID: 33320337]
27. がんサバイバーの医療利用と配偶者の精神健康の関連
Litzelman K, Choi H, Maher ME, Harnish A. Role of cancer survivor health and health service use in spouses' use of mental health-related care. Cancer. 2021;127(7):1146-53. [PMID: 33290580]
28. 乳がん長期サバイバーの併存疾患
Mohl A, Orban E, Jung AY, Behrens S, Obi N, Chang-Claude J, et al. Comorbidity burden in long-term breast cancer survivors compared with a cohort of population-based controls from the MARIE study. Cancer. 2021;127(7):1154-60. [PMID: 33259052]
29. 造血幹細胞移植患者に対するソーシャルサポートとQOLの関連
Amonoo HL, Johnson PC, Dhawale TM, Traeger L, Rice J, Lavoie MW, et al. Sharing and caring: The impact of social support on quality of life and health outcomes in hematopoietic stem cell transplantation. Cancer. 2021;127(8):1260-5. [PMID: 33598938]
30. 若年がん患者家族のSNSでの誤ったがん情報の体験
Warner EL, Waters AR, Cloyes KG, Ellington L, Kirchhoff AC. Young adult cancer caregivers' exposure to cancer misinformation on social media. Cancer. 2021;127(8):1318-24. [PMID: 33368215]
31. カナダのAYA世代がん患者のQOL
Schulte FSM, Chalifour K, Eaton G, Garland SN. Quality of life among survivors of adolescent and young adult cancer in Canada: A Young Adults With Cancer in Their Prime (YACPRIME) study. Cancer. 2021;127(8):1325-33. [PMID: 33332603]
32. 乳がん患者の倦怠感の縦断調査
Bower JE, Ganz PA, Irwin MR, Cole SW, Garet D, Petersen L, et al. Do all patients with cancer experience fatigue? A longitudinal study of fatigue trajectories in women with breast cancer. Cancer. 2021;127(8):1334-44. [PMID: 33606273]
33. 免疫療法を受けるがん患者のQOLの総説
Voon PJ, Cella D, Hansen AR. Health-related quality-of-life assessment of patients with solid tumors on immuno-oncology therapies. Cancer. 2021;127(9):1360-8. [PMID: 33662145]
34. 乳がん術後患者の抑うつ・睡眠障害に対するマインドフルネス自助介入の無作為化比較試験
Shao D, Zhang H, Cui N, Sun J, Li J, Cao F. The efficacy and mechanisms of a guided self-help intervention based on mindfulness in patients with breast cancer: A randomized controlled trial. Cancer. 2021;127(9):1377-86. [PMID: 33332582]
35. 高齢がん患者のサルコペニアとQOLの関連
Williams GR, Al-Obaidi M, Dai C, Bhatia S, Giri S. SARC-F for screening of sarcopenia among older adults with cancer. Cancer. 2021;127(9):1469-75. [PMID: 33369894]
36. 小児がん患者の家族による化学療法有害事象報告Ped-PRO-CTCAEの信頼性と妥当性
Reeve BB, McFatrich M, Lin L, Lucas NR, Mack JW, Jacobs SS, et al. Validation of the caregiver Pediatric Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events measure. Cancer. 2021;127(9):1483-94. [PMID: 33332590]
37. 化学療法中の運動療法の実施可能性
Schmitz KH, Potiaumpai M, Schleicher EA, Wolf LJ, Doerksen SE, Drabick JJ, et al. The exercise in all chemotherapy trial. Cancer. 2021;127(9):1507-16. [PMID: 33332587]
38. がんサバイバーのオピオイド鎮痛薬長期資料のリスク予測モデル
Riviere P, Vitzthum LK, Nalawade V, Deka R, Furnish T, Mell LK, et al. Validation of an oncology-specific opioid risk calculator in cancer survivors. Cancer. 2021;127(9):1529-35. [PMID: 33378556]
39. オピオイド鎮痛薬処方歴とがん発症の関連
Havidich JE, Weiss JE, Onega TL, Low YH, Goodrich ME, Davis MA, et al. The association of prescription opioid use with incident cancer: A Surveillance, Epidemiology, and End Results-Medicare population-based case-control study. Cancer. 2021;127(10):1648-57. [PMID: 33370446]
40. 小児がん長期サバイバーの痛みと機能評価の関連
Tonning Olsson I, Alberts NM, Li C, Ehrhardt MJ, Mulrooney DA, Liu W, et al. Pain and functional outcomes in adult survivors of childhood cancer: A report from the St. Jude Lifetime Cohort study. Cancer. 2021;127(10):1679-89. [PMID: 33369896]

Close